Skip to content
Menu
MedicalMVP
  • Home
  • News
  • Jobs
  • Network
    • BiotechnologyMVP
    • BusinessMVP
    • HospitalMVP
    • NursingMVP
    • PharmaceuticalMVP
    • PharmacyMVP
Close Menu

Valeant Pharmaceuticals Announces Settlement Agreement With Anacor

Medical, Pharmaceuticals, Press Releases, Valeant Pharmaceuticals

LAVAL, Quebec, Oct. 28, 2013 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has entered into a settlement agreement with Anacor Pharmaceuticals to resolve all outstanding disputes between them, including the previously disclosed disputes involving Anacor and Valeant’s subsidiaries, Dow Pharmaceutical Sciences, Inc. (Dow) and Medicis Pharmaceutical Corporation.

Anacor and Valeant agreed that Valeant would pay Anacor $142.5 million to settle all existing and future claims related to Anacor’s intellectual property, confidential information and contractual rights, and the payment includes the previously announced interim final award of damages and legal fees related to Anacor’s contractual dispute with Dow. Valeant has agreed to make payment to Anacor no later than November 8, 2013.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE and TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Forward-looking Statements

This press release may contain forward-looking statements, including, but not limited to, statements regarding the settlement with Anacor. Forward-looking statements may generally be identified by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the uncertainty associated with the settlement and the risks and uncertainties discussed in the Company’s most recent annual or quarterly report and detailed from time to time in Valeant’s other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Valeant undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.

SOURCE Valeant Pharmaceuticals International, Inc.

Related Posts

Press Releases

Blue Cross and Blue Shield Companies Join Forces with Civica Rx to Lower Costs of Select High-Cost Generic Medications

Press Releases

Teladoc Health to Acquire InTouch Health

Press Releases

Vivante Health Snags DebraAnn Braun as Chief Technology Officer

Medical News

  • Blue Cross and Blue Shield Companies Join Forces with Civica Rx to Lower Costs of Select High-Cost Generic Medications
  • Teladoc Health to Acquire InTouch Health
  • Vivante Health Snags DebraAnn Braun as Chief Technology Officer
  • Dr. Jason Hallock Joins SOC Telemed as Chief Medical Officer
  • Change Healthcare Unveils API & Services Connection, a Marketplace to Accelerate Innovation in Healthcare

Featured Jobs

  • MGR- OBSERVATION CENTER 8SOUTH

    • Lansing, MI
    • Sparrow Health System
    • Full Time
  • SURG TECHNOLOGIST-CERT

    • Lansing, MI
    • Sparrow Health System
    • Full Time
  • ADM – ORTHOPEDICS 6W

    • Lansing, MI
    • Sparrow Health System
    • Full Time
  • ADM – MEDICAL ICU 10W

    • Lansing, MI
    • Sparrow Health System
    • Full Time
  • SHS-MGR CLINICAL INTEGRATION

    • Lansing, MI
    • Sparrow Health System
    • Full Time
Back To Top
MedicalMVP
Copyright © BusinessMVP.com
All Rights Reserved!